OTCMKTS:APNHY - Aspen Pharmacare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$19.85 -0.48 (-2.35 %)
(As of 05/24/2018 04:00 PM ET)
Previous Close$20.3275
Today's Range$19.50 - $20.06
52-Week Range$19.45 - $24.60
Volume19,674 shs
Average Volume30,494 shs
Market Capitalization$9.48 billion
P/E Ratio180.45
Dividend Yield0.71%
Beta0.05

About Aspen Pharmacare (OTCMKTS:APNHY)

Aspen Pharmacare logoAspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies branded, OTC, and generic pharmaceutical products, infant nutritionals, and consumer healthcare products. The company offers various branded products for a range of therapeutic categories, including anaesthetics, analgesics, anti-retrovirals, blood and haemopoetic, cardio vascular system, central nervous system, endocrine system, gastro-intestinal tract, infant milk formulations, musculo-skeletal agents, NSAids, oncology, oral hygiene, respiratory system, and urinary tract system, as well as ear, nose, and throat. It also provides various generics covering a range of categories, such as anti-depressants; analgesics for pain relief; anti-hypertensives for high blood pressure; bronchodilators for the treatment of asthma; anti-bacterials to treat bacterial infections; anti-gout agents; anti-inflammatory agents; anti-fungal agents; anti-histamines for the treatment of allergies; decongestants; gastro-intestinal agents; dermatologicals; and anti-retrovirals. In addition, the company manufactures narcotic and specialist fine active pharmaceutical ingredients. The company serves pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders, and retail stores across the private and public sectors. It has operations in South Africa, the Asia Pacific, Europe CIS, Latin America, Sub-Saharan Africa, the Middle East, North Africa, the United States, and Canada. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.

Receive APNHY News and Ratings via Email

Sign-up to receive the latest news and ratings for APNHY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:APNHY
CUSIPN/A
Phone27-31-580-8600

Debt

Debt-to-Equity Ratio0.67
Current Ratio0.89
Quick Ratio0.56

Price-To-Earnings

Trailing P/E Ratio180.45
Forward P/E Ratio13.60
P/E Growth1.29

Sales & Book Value

Annual Sales$3.03 billion
Price / Sales2.99
Cash Flow$1.2314 per share
Price / Cash16.12
Book Value$6.94 per share
Price / Book2.86

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees10,204
Outstanding Shares456,450,000

Aspen Pharmacare (OTCMKTS:APNHY) Frequently Asked Questions

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the OTCMKTS under the ticker symbol "APNHY."

Who are some of Aspen Pharmacare's key competitors?

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the folowing people:
  • Mr. Stephen Bradley Saad BCom, CA(SA), Group CEO & Exec. Director (Age 54)
  • Mr. Michael Guy Attridge BCom, CA(SA), Deputy Group Chief Exec. & Exec. Director (Age 57)
  • Mr. Sean M. Capazorio, Group Fin. Officer (Age 51)
  • Ms. Lorraine Hill, Group Operating Officer (Age 54)
  • Mr. Riaan Verster BProc, LLB, LLM, ACIS, Company Sec., Group Governance Officer & Group Compliance Officer (Age 42)

Has Aspen Pharmacare been receiving favorable news coverage?

Media stories about APNHY stock have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aspen Pharmacare earned a media sentiment score of 0.21 on Accern's scale. They also assigned media headlines about the company an impact score of 47.67 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Aspen Pharmacare?

Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aspen Pharmacare's stock price today?

One share of APNHY stock can currently be purchased for approximately $19.85.

How big of a company is Aspen Pharmacare?

Aspen Pharmacare has a market capitalization of $9.48 billion and generates $3.03 billion in revenue each year. The company earns $374.85 million in net income (profit) each year or $0.11 on an earnings per share basis. Aspen Pharmacare employs 10,204 workers across the globe.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is Aspen Place 9 Rydall Vale Park, Durban T3, 4019. The company can be reached via phone at 27-31-580-8600.


MarketBeat Community Rating for Aspen Pharmacare (APNHY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Aspen Pharmacare and other stocks. Vote "Outperform" if you believe APNHY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APNHY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aspen Pharmacare (OTCMKTS:APNHY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/24/2016 forward)

Earnings

Dividends

Aspen Pharmacare (OTCMKTS:APNHY) Dividend Information

Aspen Pharmacare pays an annual dividend of $0.15 per share, with a dividend yield of 0.76%. Aspen Pharmacare pays out 136.36% of its earnings out as a dividend.
Annual Dividend:$0.15
Dividend Yield:0.76%
Payout Ratio(s):136.36% (Trailing 12 Months of Earnings)
10.27% (Based on This Year's Estimates)
9.43% (Based on Next Year's Estimates)
12.18% (Based on Cash Flow)
Dividend Payments by Quarter for Aspen Pharmacare (OTCMKTS:APNHY)

Aspen Pharmacare (OTCMKTS:APNHY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Aspen Pharmacare (OTCMKTS APNHY) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.04%
Insider Trading History for Aspen Pharmacare (OTCMKTS:APNHY)

Aspen Pharmacare (OTCMKTS APNHY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Aspen Pharmacare (OTCMKTS APNHY) News Headlines

Source:
DateHeadline
Aspen Pharmacare (APNHY) Stock Rating Lowered by Zacks Investment ResearchAspen Pharmacare (APNHY) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 17 at 4:47 PM
Aspen Pharmacare (APNHY) Upgraded at Zacks Investment ResearchAspen Pharmacare (APNHY) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 16 at 4:48 PM
Aspen Pharmacare Expected to Post FY2018 Earnings of $1.50 Per Share (APNHY)Aspen Pharmacare Expected to Post FY2018 Earnings of $1.50 Per Share (APNHY)
www.americanbankingnews.com - April 16 at 2:33 AM
Aspen Pharmacare (APNHY) Cut to Hold at Zacks Investment ResearchAspen Pharmacare (APNHY) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - March 20 at 6:30 PM
Aspen Pharmacare (APNHY) Lifted to "Buy" at Zacks Investment ResearchAspen Pharmacare (APNHY) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - February 8 at 4:22 PM
Aspen Pharmacare (APNHY) Downgraded to "Hold" at Zacks Investment ResearchAspen Pharmacare (APNHY) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - February 1 at 4:58 PM
Zacks Investment Research Upgrades Aspen Pharmacare (APNHY) to BuyZacks Investment Research Upgrades Aspen Pharmacare (APNHY) to Buy
www.americanbankingnews.com - January 30 at 4:52 PM
FY2018 Earnings Estimate for Aspen Pharmacare (APNHY) Issued By Jefferies GroupFY2018 Earnings Estimate for Aspen Pharmacare (APNHY) Issued By Jefferies Group
www.americanbankingnews.com - January 19 at 5:16 PM
FY2022 Earnings Forecast for Aspen Pharmacare Issued By Jefferies Group (APNHY)FY2022 Earnings Forecast for Aspen Pharmacare Issued By Jefferies Group (APNHY)
www.americanbankingnews.com - January 18 at 11:32 PM
Aspen Pharmacare Holdings Ltd. : Neutral assessment on price but strong on fundamentalsAspen Pharmacare Holdings Ltd. : Neutral assessment on price but strong on fundamentals
finance.yahoo.com - December 13 at 4:25 PM
FY2018 Earnings Estimate for Aspen Pharmacr (APNHY) Issued By Jefferies GroupFY2018 Earnings Estimate for Aspen Pharmacr (APNHY) Issued By Jefferies Group
www.americanbankingnews.com - December 4 at 10:34 AM
Brokers Offer Predictions for Aspen Pharmacrs FY2020 Earnings (APNHY)Brokers Offer Predictions for Aspen Pharmacr's FY2020 Earnings (APNHY)
www.americanbankingnews.com - December 2 at 10:00 AM

SEC Filings

Aspen Pharmacare (OTCMKTS:APNHY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Aspen Pharmacare (OTCMKTS APNHY) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.